Skip to Content

Alitretinoin topical Pregnancy and Breastfeeding Warnings

Alitretinoin topical is also known as: Panretin

Alitretinoin topical Pregnancy Warnings

Alitretinoin topical has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of fetotoxicity and teratogenicity with oral doses of alitretinoin above the recommended human dose (adjusted for body surface area). Topical alitretinoin has not been studied in animal models. There are no controlled data in human pregnancy. Patients should be advised of the potential harm to the fetus if alitretinoin topical is used during pregnancy or if they become pregnant while using it. Women of childbearing potential should be advised to avoid becoming pregnant. Alitretinoin topical is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Alitretinoin topical Breastfeeding Warnings

There are no data on the excretion of alitretinoin topical into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, mothers should discontinue nursing prior to using the drug.

See references

References for pregnancy information

  1. "Product Information. Panretin (alitretinoin topical)." Ligand Pharmaceuticals, San Diego, CA.

References for breastfeeding information

  1. "Product Information. Panretin (alitretinoin topical)." Ligand Pharmaceuticals, San Diego, CA.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.